Biocardia (BCDA)CEO bought ~$5.3K

~$5.3K

Approx. value · 5,500 sh @ $0.97

367K

Holds after · shares reported

Traded

Jul 8, 2026

Filed

Jul 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 15, 2026Company filing · Form 8-K · ResultsReported its results
2. May 15, 2026InsiderCEO purchased ~$5.2K of BCDA shares in the open market
3. May 18, 2026InsiderCEO purchased ~$5.2K of BCDA shares in the open market
4. May 19, 2026InsiderCEO purchased ~$190 of BCDA shares in the open market
5. May 20, 2026InsiderCEO purchased ~$1.4K of BCDA shares in the open market
6. Jun 9, 2026Insider · 3 days before an 8-KCEO purchased ~$4.3K of BCDA shares in the open market
7. Jun 12, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“As previously disclosed on that certain Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2026 (the “Original 8-K”), on April 10, 2026, BioCardia, Inc. (the “Company,” “we,” “us” and “our”) received a notification letter (the “Notice”) from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its…”
8. Jun 17, 2026InsiderCEO purchased ~$1.3K of BCDA shares in the open market
9. Jun 18, 2026InsiderCEO purchased ~$768 of BCDA shares in the open market
10. Jun 22, 2026InsiderDirector purchased ~$65K of BCDA shares in the open market
11. Jun 23, 2026InsiderDirector purchased ~$39K of BCDA shares in the open market
12. Jul 8, 2026 · this disclosureInsiderCEO purchased ~$5.3K of BCDA shares in the open market

What came next

1. Jul 8, 2026InsiderCEO purchased ~$5.2K of BCDA shares in the open market
2. Jul 9, 2026InsiderCEO purchased ~$900 of BCDA shares in the open market
3. Jul 10, 2026InsiderCEO purchased ~$940 of BCDA shares in the open market
4. Jul 14, 2026InsiderCEO purchased ~$2.5K of BCDA shares in the open market
5. Jul 15, 2026InsiderCEO purchased ~$1.3K of BCDA shares in the open market
6. Jul 17, 2026InsiderCEO purchased ~$415 of BCDA shares in the open market
7. Jul 29, 2026Insider · 14 days before resultsCEO purchased ~$3.9K of BCDA shares in the open market
8. Aug 12, 2026Company filing · Form 8-K · ResultsReported its results
9. Aug 13, 2026Insider · 6 days before an 8-KCEO purchased ~$1.7K of BCDA shares in the open market
10. Aug 17, 2026Insider · 2 days before an 8-KCEO purchased ~$5K of BCDA shares in the open market
11. Aug 19, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On August 19, 2026, BioCardia, Inc. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the minimum bid price of the Company’s common stock had been below the $1.00 per share minimum requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing…”
12. Sep 3, 2026InsiderCEO purchased ~$872 of BCDA shares in the open market
13. Sep 23, 2026InsiderCEO purchased ~$2K of BCDA shares in the open market
14. Sep 29, 2026InsiderCEO purchased ~$1K of BCDA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biocardia

For Biocardia, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCDA page.

Other recent filings by Peter Altman, President and CEO

• SEC Form 4 at Biocardia (BCDA)Sep 30, 2026
• SEC Form 4 at Biocardia (BCDA)Sep 24, 2026
• SEC Form 4 at Biocardia (BCDA)Sep 5, 2026
• SEC Form 4 at Biocardia (BCDA)Aug 18, 2026
• SEC Form 4 at Biocardia (BCDA)Aug 13, 2026

The full history of Peter Altman, President and CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Biocardia

• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 24, 2026
• SEC Form 4Sep 5, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 13, 2026
• SEC Form 4Jul 30, 2026

Everything OQRO holds on this company is on its BCDA page.